Bridging Science and Commercialization for Impact

Specializing in sustainable innovation, Elizabeth Loennborn empowers startups in deep tech and biotech with data-driven strategies that transform ideas into market-ready solutions.

Driving Sustainable Innovation for Impactful Growth

Explore critical data points that reveal operational success and market influence.

Startups Supported

Collaborated with over 150 startups to implement data-driven growth strategies.

Projects Accelerated

Successfully accelerated 85 deep tech and biotech projects toward commercialization.

Sustainability Initiatives

Led 75 initiatives focusing on scalable, measurable climate tech solutions.

Market Penetration

Achieved 95% market readiness for supported startups through strategic planning.

Insights

Explore a curated collection of articles and expert perspectives on sustainable innovation and technology trends to keep you informed and inspired.

Elizabeth Loennborn

Sustainable Innovation Strategist

Elizabeth Loennborn specializes in sustainable innovation, merging deep tech, climate tech, and biotech expertise. She focuses on operational strategies and scaling startups, delivering data-driven market readiness solutions.

Connecting Sustainable Innovation with Commercial Success

Discover how Elizabeth’s expertise accelerates your startup’s growth through strategic, data-driven solutions designed for measurable impact. Get started today to transform your ideas into market-ready ventures.

Drive Sustainable Innovation with Proven Strategies

Discover how Elizabeth Loennborn combines science and commercialization to accelerate deep tech and climate solutions.

Strategic Scaling Support

Leverage data-driven operational planning to efficiently grow startups and optimize market readiness.

Bridging Science and Business

Integrate cutting-edge biotechnology expertise with commercialization strategies to maximize impact.

Commitment to Measurable Impact

Focus on actionable solutions that deliver real-world results in climate tech and biotech sectors.